<DOC>
	<DOC>NCT00904215</DOC>
	<brief_summary>An observational study to investigate the efficacy, safety, tolerability and the effect on quality of life of Telmisartan (Micardis) and Telmisartan with HCTZ (Micardis Plus) in patients with hypertension</brief_summary>
	<brief_title>An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>1. Ability to provide written/verbal informed consent in accordance with GCP (Good Clinical Practice) and local legislation 2. Patients aged 18 ~ under 80 3. Hypertension as described below: Newly diagnosed patients with hypertension Patients with current antihypertensive therapy 1. Female subjects who are breastfeeding, pregnant or who plan to be pregnant during the study 2. Known or suspected secondary hypertension(e.g. pheochromocytoma) 3. Patients who have been treated with telmisartan prior to the acquisition of informed consent (including verbal informed consent)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>